Dr. Christel Fenge has been named vice president of marketing for Fermentation Technologies at Sartorius Stedim Biotech. She will be responsible for the global management of the product portfolio of multi- and single-use bioreactors.

Most recently Ms. Fenge served as general manager of Recipharm Biologics. Previous potions included senior management positions in biopharmaceutical development at AstraZeneca. She began her career in cell culture process development at Pharmacia & Upjohn and in product management at B.Braun Biotech.

“We are extremely pleased to have Dr. Fenge join our organization to strengthen our Fermentation Technology activities, particularly with regard to implementing and supporting our single-use technology approach she will play an essential role,” said Reinhard Vogt, member of the board of Sartorius Stedim Biotech. “She brings with her an exceptional experience base of cell culture and protein science, which will further our customer support and technology bases.”